We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.



Your filtered view of the latest news and analysis

  • Benchmark in growth mode

    28 January 2015

    Aim-traded biotech outfit Benchmark Holdings saw sales - and costs - soar last year.
  • GSK needs action plan

    27 January 2015

    Drugs giant GlaxoSmithKline needs to address some serious health issues to pep up its flagging top line.
  • Consort chief spies recovery

    15 January 2015

    Jonathan Glenn, chief executive at Consort Medical, has realised some value following a slight recovery in the company's share price
  • Shire moves on from AbbVie Tip Update

    14 January 2015

    Shire has put its failed merger with AbbVie behind it by picking up US-based biotech business NPS Pharmaceuticals.
  • Horizon seals new deal Tip Update

    09 January 2015

    Shares in Horizon Discovery (HZD) have rocketed in value lately and its latest acquisition could be the reason.

Register today and get...

Register today and get...
Please note terms & conditions apply